Inspire Medical Systems, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Inspire Medical Systems, Inc. (INSP) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $26.40 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-02-13
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $26.40M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $34.00M.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $41.80M.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $56.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $26.40M 10-K · filed 2026-02-13 |
| 2025-09-30 | $34.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $41.80M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $56.70M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $68.00M 10-K · filed 2025-02-10 |
| 2024-09-30 | $79.40M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $91.40M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $105.90M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $99.60M 10-K · filed 2024-02-09 |
| 2023-09-30 | $111.10M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $118.70M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $122.80M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $87.00M 10-K · filed 2023-02-10 |
| 2022-09-30 | $89.60M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $90.70M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $94.20M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $67.50M 10-K · filed 2022-02-15 |
| 2021-09-30 | $70.00M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $73.10M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $72.40M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $72.70M 10-K · filed 2021-02-24 |
| 2020-09-30 | $32.90M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $33.90M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $33.00M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $33.90M 10-K · filed 2020-02-25 |
| 2019-09-30 | $18.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $15.70M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $15.60M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $15.50M 10-K · filed 2019-02-26 |
| 2018-09-30 | $2.40M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.20M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |